Correlation Between Molecular Partners and Biocardia
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Biocardia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Biocardia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Biocardia, you can compare the effects of market volatilities on Molecular Partners and Biocardia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Biocardia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Biocardia.
Diversification Opportunities for Molecular Partners and Biocardia
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Molecular and Biocardia is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Biocardia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biocardia and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Biocardia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biocardia has no effect on the direction of Molecular Partners i.e., Molecular Partners and Biocardia go up and down completely randomly.
Pair Corralation between Molecular Partners and Biocardia
Given the investment horizon of 90 days Molecular Partners AG is expected to under-perform the Biocardia. But the stock apears to be less risky and, when comparing its historical volatility, Molecular Partners AG is 1.18 times less risky than Biocardia. The stock trades about -0.03 of its potential returns per unit of risk. The Biocardia is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 239.00 in Biocardia on September 2, 2024 and sell it today you would lose (11.00) from holding Biocardia or give up 4.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Biocardia
Performance |
| Timeline |
| Molecular Partners |
| Biocardia |
Molecular Partners and Biocardia Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Biocardia
The main advantage of trading using opposite Molecular Partners and Biocardia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Biocardia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocardia will offset losses from the drop in Biocardia's long position.| Molecular Partners vs. Tff Pharmaceuticals | Molecular Partners vs. Eliem Therapeutics | Molecular Partners vs. Inhibrx | Molecular Partners vs. Enliven Therapeutics |
| Biocardia vs. Aerovate Therapeutics | Biocardia vs. Adagene | Biocardia vs. Acrivon Therapeutics, Common | Biocardia vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |